1. Delgado V, Ajmone Marsan N, de Waha S, et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44: 3948-4042.
2.
Mostaghim AS, Lo HYA, Khardori N. A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital. SAGE Open Med 2017; 5: 2050312117741772.
3.
Monteiro TS, Correia MG, Golebiovski WF, et al. Asymptomatic and symptomatic embolic events in infective endocarditis: associated factors and clinical impact. Braz J Infect Dis 2017; 21: 240-7.
4.
Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association. Circulation 2015; 132: 1435-86.
5.
Hu W, Wang X, Su G. Infective endocarditis complicated by embolic events: pathogenesis and predictors. Clin Cardiol 2021; 44: 307-15.
6.
Sambola A, Lozano-Torres J, Boersma E, et al. Predictors of embolism and death in left-sided infective endocarditis: the European Society of Cardiology EURObservational Research Programme European Infective Endocarditis registry. Eur Heart J 2023; 44: 4566-75.
7.
Şimşek-Yavuz S, Şensoy A, Kaşıkçıoğlu H, et al. Infective endocarditis in Turkey: aetiology, clinical features, and analysis of risk factors for mortality in 325 cases. Int J Infect Dis 2015; 30: 106-14.
8.
Çakır H, Uysal S, Karagöz A, et al. The clinical course of infective endocarditis and independent predictors of in-hospital mortality. Koşuyolu Heart J 2022; 25: 115-21.
9.
Kılıç O, Yılmaz S. İnfektif Endokardit ile Başvuran Hastalarda Hastane İçi Mortalitenin Öngördürücüleri: Tek Merkezli Çalışma. MN Kardiyoloji 2019; 26: 58-9.
10.
Özkan U, Gürdoğan M. A novel potential biomarker for predicting the development of septic embolism in patients with infective endocarditis: systemic coagulation inflammation index. Turk Kardiyol Dern Ars 2024; 52: 36-43.
11.
Anguera I, Miro JM, Vilacosta I, et al. Aorto-cavitary fistulous tract formation in infective endocarditis: clinical and echocardiographic features of 76 cases and risk factors for mortality. Eur Heart J 2005; 26: 288-97.
12.
Cabell CH, Pond KK, Peterson GE, et al. The risk of stroke and death in patients with aortic and mitral valve endocarditis. Am Heart J 2001; 142: 75-80.
13.
Mohananey D, Mohadjer A, Pettersson G, et al. Association of vegetation size with embolic risk in patients with infective endocarditis a systematic review and meta-analysis. JAMA Intern Med 2018; 178: 502-10.
14.
Young WJ, Hoare D, Bvekerwa I, et al. Association of vegetation size with valve destruction, embolism and mortality. Heart Lung Circ 2021; 30: 854-60.
15.
Garcia-Cabrera E, Fernandez-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation 2013; 127: 2272-84.
16.
Hubert S, Thuny F, Resseguier N, et al. Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort. J Am Coll Cardiol 2013; 62: 1384-92.
17.
Mohananey D, Mohadjer A, Pettersson G, et al. Association of vegetation size with embolic risk in patients with infective endocarditis: a systematic review and meta-analysis. JAMA Intern Med 2018; 178: 502-10.
18.
Barış VÖ, Kılıçkap M, Göksülük H, et al. D-Dimer is a strong predictor of in-hospital mortality in patients with infective endocarditis. Anatol J Cardiol 2019; 21: 124-33.
19.
Karaca B, Esin F, Tiryaki MM, et al. Combining C-reactive protein, procalcitonin, and serum albumin to predict long-term mortality in patients with infective endocarditis. J Int Med Res 2023; 51: 3000605231208910.
20.
Huang S, Zhou Z, Luo L, et al. Preoperative serum albumin: a promising indicator of early mortality after surgery for infective endocarditis. Ann Transl Med 2021; 9: 1445.
21.
Baykiz D, Govdeli EA, Demirtakan ZG, et al. Prognostic value of the C-reactive protein-to-albumin ratio in patients with infective endocarditis. Eur Rev Med Pharmacol Sci 2022; 26: 8728-37.